, соответствующих корпоративной культуре Bereke Bank. Воплощая инновации в жизнь и стремительно развиваясь, мы открываем широкие... дэшбордов, понятных процессов принятия решений. Мы работаем в Bereke Bank и знаем из личного опыта, как это увлекательно...
как Allur, Jusan Bank, Yandex, Pari Match, L'Oréal, BI Group и RG Brands. Мы — в топ-10 агентств Центральной Азии по... event-услуг Казахстана. С нами сотрудничают крупные и локальные международные компании, такие как Allur, Jusan Bank, Pari...
Headquartered in St. Lucia, West Indies, Euro Exim Bank is an award-winning international trade finance institution... (Stand-by Letter of Credit), BG (Bank Guarantee) necessary for them to trade successfully in the global market. Identify...
выпускать не только клиентские, но и собственные цифровые продукты, один из основных — Ready Bank. Основные направления... Bank – готовые решения для запуска цифрового Банка: Мобильные приложения ДБО Юл и Физ лиц, операционная CRM, универсальный...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »